Search Results

Intuitive announced that it has become the largest provider of robotic-assisted surgical technology training to be accredited by the Royal College of Surgeons of England.

Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce today that they have entered into an agreement with the KTH Royal Institute of Technology to utilise KTH’s state-of-the-art supercomputer resources for analysing protein structures.

Scandinavian ChemoTech’s fully owned subsidiary Vetiqure receives very promising updates from the veterinarians at the Royal Veterinary College, who will now continue to treat more patients.

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that SHIELD I Phase 3 clinical data for D-PLEX100 will be highlighted in a presentation at the American College of Surgeons Clinical Congress 2023, to be held on October 22-25, 2023, in Boston, MA.

Mytonomy Inc., a leader in cloud solutions for health education and engagement, announced that the company is a proud participant of the American Academy of Orthopaedic Surgeons’ Patient-Reported Outcome Measures Vendor Program.

DIAGNOSTIC GREEN, the leading provider of Indocyanine Green (ICG) worldwide, is pleased to announce a day long training session on ICG as well as multiple other talks on ICG at the upcoming AMERICAN COLLEGE OF SURGEONS (ACS) Clinical Congress in Boston, MA, from October 22–25.

Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Roger A. Goldberg, MD, MBA, a vitreoretinal surgeon at Bay Area Retina Associates (BARA) to its Scientific Advisory Board. As an advisor, Dr. Goldberg will contribute scientific insights and valued clinical perspectives to aid Kiora’s development of new therapeutics to address retinal diseases with high unmet needs.

RaySearch Laboratories AB is proud to announce that The Royal Marsden NHS Foundation Trust, a specialist cancer center in the UK, will be the first in the world to implement online adaptive radiation therapy with RaySearch’s treatment planning system RayStation®* and oncology information system RayCare®* - including the new ARTemis* OART solution under development - in combination with the Radixact® Treatment Delivery System from Accuray.